CUSIP 01021M104 · who reports it, how much, and how much it matters to them
14 of the 720 hedge fund managers we track reported shares of Aktis Oncology, Inc. (Nasdaq: AKTS) on Form 13F for 30 June 2026. Between them they reported USD 328m. The largest position belongs to ECOR1 Capital, at USD 155m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | ECOR1 Capital3 funds on PPLI.com | USD 155m | 7.6% |
| 2 | RTW Investments2 funds on PPLI.com | USD 51m | 0.4% |
| 3 | Ra Capital Management1 fund on PPLI.com | USD 42m | 0.4% |
| 4 | Baker Bros. Advisors2 funds on PPLI.com | USD 32m | 0.2% |
| 5 | Octagon Capital Advisors1 fund on PPLI.com | USD 31m | 2.8% |
| 6 | Arrowmark Colorado Holdings24 funds on PPLI.com | USD 7.9m | 0.3% |
| 7 | Renaissance Technologies13 funds on PPLI.com | USD 3.1m | 0.0% |
| 8 | Squarepoint Ops7 funds on PPLI.com | USD 1.2m | 0.0% |
| 9 | Sofinnova Investments1 fund on PPLI.com | USD 1m | 0.1% |
| 10 | Two Sigma Investments35 funds on PPLI.com | USD 996,000 | 0.0% |
| 11 | Citadel Advisors32 funds on PPLI.com | USD 823,000 | 0.0% |
| 12 | Tudor Investment Corporation10 funds on PPLI.com | USD 690,000 | 0.0% |
| 13 | The Quarry1 fund on PPLI.com | USD 1,096 | 0.0% |
| 14 | Freestone Grove Partners1 fund on PPLI.com | USD 64 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | ECOR1 Capital | USD 155m | 7.6% |
| 2 | Octagon Capital Advisors | USD 31m | 2.8% |
| 3 | RTW Investments | USD 51m | 0.4% |
| 4 | Ra Capital Management | USD 42m | 0.4% |
| 5 | Arrowmark Colorado Holdings | USD 7.9m | 0.3% |
| 6 | Baker Bros. Advisors | USD 32m | 0.2% |
| 7 | Sofinnova Investments | USD 1m | 0.1% |
| 8 | Renaissance Technologies | USD 3.1m | 0.0% |
| 9 | Squarepoint Ops | USD 1.2m | 0.0% |
| 10 | Two Sigma Investments | USD 996,000 | 0.0% |
Aktis Oncology, Inc. trades under the symbol AKTS on the Nasdaq. Its CUSIP, the code used on Form 13F, is 01021M104.
14 of the 720 hedge fund managers PPLI.com tracks reported Aktis Oncology, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by ECOR1 Capital (USD 155m), RTW Investments (USD 51m), Ra Capital Management (USD 42m), Baker Bros. Advisors (USD 32m) and Octagon Capital Advisors (USD 31m).
14 managers in our coverage reported it, and between them they run 133 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
ECOR1 Capital, where the position was 7.6% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Aktis Oncology, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.